Lifeward

Lifeward Equity Ratio

The Equity Ratio of Lifeward (LFWD) as of Nov 22, 2026 is 36.72 %. In the previous year, Equity Ratio was 61.83 % — a change of -40.61% (lower).

Equity Ratio

36.72 %

YoY

-40.61%

Last updated:

Equity Ratio of Lifeward is 2025 36.72 % . Equity Ratio of Lifeward was 2024 61.83 % . It decreases by -40.61% lower compared to the previous year.

The Lifeward Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
13.00 USD
Jan 1, 2019
44.23 USD
Jan 1, 2020
77.58 USD
Jan 1, 2021
94.34 USD
Jan 1, 2022
91.82 USD
Jan 1, 2023
73.60 USD
Jan 1, 2024
61.83 USD
Jan 1, 2025
36.72 USD
The Lifeward Equity Ratio history
YEAREquity RatioYoY
36.72 %-40.61%
61.83 %-16.00%
73.60 %-19.84%
91.82 %-2.66%
94.34 %+21.60%
77.58 %+75.39%
44.23 %+240.25%
13.00 %-19.82%
16.21 %-37.65%
26.01 %-68.21%
81.80 %-11.09%
92.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

Equity Ratio of Lifeward is 36.72 % in 2025.

Equity Ratio of Lifeward changed from 61.83 % to 36.72 %, representing a -40.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Lifeward since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Lifeward with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Lifeward

All Key Metrics — Lifeward